⚠️ Schedule H/H1: Prescription required. Do not self-medicate.
1. Clinical Overview
Afogatran 150 Capsule contains Dabigatran Etexilate (150mg), a direct thrombin inhibitor anticoagulant for prevention of stroke in atrial fibrillation and treatment of thromboembolism.
| Manufacturer | Form | Pack Size |
|---|---|---|
| Torrent Pharmaceuticals Ltd | allopathy | strip of 10 capsules |
2. Side Effects
Possible side effects associated with Afogatran 150 Capsule:
- Common: bleeding (nose
- GI
- hematuria)
- dyspepsia. Serious: major hemorrhage
- hemorrhagic stroke. Contraindicated in active pathological bleeding
- mechanical heart valve.
4. Trusted Substitutes (Same Salt)
Medicines with the same composition (Dabigatran Etexilate (150mg)):
| Brand Name | Manufacturer | Action |
|---|---|---|
| Bigatra 150mg Tablet | Aprica Pharmaceuticals Pvt Ltd | View Details |
| Dabigo 150mg Capsule | Sun Pharmaceutical Industries Ltd | View Details |
| Dabistar 150 Capsule | Lupin Ltd | View Details |
| Dabiclot 150mg Capsule | Alkem Laboratories Ltd | View Details |
| Dablexa 150 Capsule | Abbott | View Details |
| Dabigat 150 Capsule | Natco Pharma Ltd | View Details |